Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 075 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 075 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium chloride maintains intracellular tonicity and is essential for nerve conduction, muscle contraction, and acid-base balance. Dextrose provides calories and may decrease protein and nitrogen loss. Sodium chloride maintains extracellular fluid volume and electrolyte balance.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion; rate determined by fluid and electrolyte needs; typical adult rate: 100-200 mL/hour (contains 10 g dextrose, 9 mEq sodium, 0.075 g potassium chloride per 100 mL); maximum potassium infusion rate: 10 mEq/hour (13.3 mL/hour of this solution) unless critical hypokalemia.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Potassium has no true elimination half-life due to tight homeostatic regulation; the terminal half-life of potassium tracer is approximately 12-14 hours in healthy individuals. Clinically, redistribution half-life is ~1 hour. Effect persists as long as infusion continues, with transient changes after cessation.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Potassium is primarily excreted renally (approximately 90%) via glomerular filtration and distal tubular secretion. Fecal elimination accounts for ~10% under normal conditions. Dextrose and sodium chloride are fully metabolized or excreted renally.
Category C
Category A/B
Electrolyte
Electrolyte